For the dataset of all mutations, the cancer type-specific six gene mutation biomarkers were APC for colorectal cancer, PTEN for endometrial cancer, BRAF for thyroid cancer and MUC16, DNAH5, TTN for cutaneous melanoma. This evidence concerns the gene MUC16 and endometrial cancer.